Microbial production of piceatannol: current status and future prospects
Piceatannol is a plant-derived stilbenoid compound, exhibiting physiological activities such as antioxidant, anti-inflammatory, and anti-tumor effects, which endow it with significant application value in the food, pharmaceutical, and cosmetic industries. In recent years, the biosynthesis of piceatannol via microbial cell factories has attracted widespread attention, as it provides a safe and efficient route for the production of this compound. This review begins by introducing the biosynthetic pathway and relevant enzymes of piceatannol, followed by an in-depth analysis of the characteristics of microbial hosts used for its production. Subsequently, the main strategies for piceatannol production in microbial hosts, including the construction of efficient heterologous biosynthetic pathways, directed engineering of rate-limiting enzymes, supply of cofactors, enhancement of precursor metabolic flux, and optimization of the production process, are systematically summarized and discussed. Finally, the future prospects and perspectives for the microbial production of piceatannol are discussed.
Authors
- 王凤寰 (ORCID: https://orcid.org/0000-0003-2498-3673)
- Chao Feng (ORCID: https://orcid.org/0000-0002-1422-0296)
- Yuanzi Li
- Miao Zhang (ORCID: https://orcid.org/0000-0001-9814-2573)
- Siqi Hu
- Minyong Zhong
- Jianghao Ding
- Zhengrong Tao
Institutions
- Beijing Technology and Business University (CN)
- Tongde Hospital of Zhejiang Province (CN)
- China Academy of Chinese Medical Sciences (CN)
- Beijing Automotive Group (China) (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fmicb.2026.1965733
- Primary Topic
- Microbial Metabolic Engineering and Bioproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Beijing Technology and Business University
- China Academy of Chinese Medical Sciences